Get the Stockscreener App
1.815
1.97%
0.035
After Hours:
1.82
0.005
+0.28%
China Pharma Holdings Inc. stock is traded at $1.815, with a volume of 1,678.
It is up +1.97% in the last 24 hours and up +8.04% over the past month.
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.
See More
Previous Close:
$1.78
Open:
$1.85
24h Volume:
1,678
Relative Volume:
0.02
Market Cap:
$5.92M
Revenue:
$5.54M
Net Income/Loss:
$-4.74M
P/E Ratio:
-5.4018
EPS:
-0.336
Net Cash Flow:
$-750.60K
1W Performance:
+0.28%
1M Performance:
+8.04%
6M Performance:
-0.55%
1Y Performance:
-29.73%
1-Day Range:
$1.81
$1.85
1-Week Range:
$1.70
$1.88
52-Week Range:
$1.20
$3.35
China Pharma Holdings Inc. Stock (CPHI) Company Profile
Name
China Pharma Holdings Inc.
Sector
Phone
86 898 6681 1730
Address
No. 17, Jinpan Road, Second Floor, Haikou
Compare CPHI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CPHI
China Pharma Holdings Inc.
|
1.815 | 5.81M | 5.54M | -4.74M | -750.60K | -0.336 |
|
ZTS
Zoetis Inc
|
153.45 | 67.31B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.74 | 45.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.75 | 43.35B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.58 | 18.68B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
305.61 | 13.44B | 2.99B | 1.21B | 1.13B | 25.06 |
China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-10 | Initiated | Rodman & Renshaw | Mkt Outperform |
China Pharma Holdings Inc. Stock (CPHI) Latest News
Is AGNC a good long term investmentConsistent triple-digit returns - Autocar Professional
What analysts say about SFBC stockFree Stock Market Return Analysis - Autocar Professional
Would You Accumulate or Wait on Shivam Autotech Limited (532776)Robust investment performance - jammulinksnews.com
Titan Acquisition Corp Debt Equity Composite Units Stock Analysis and ForecastSkyrocketing investment returns - Autocar Professional
Brightcom Group Limited (532368) Hits 52 Week HighUnprecedented profits - jammulinksnews.com
India Stocks with Potential to Double by 2025 Professional Trading GuidanceRapidly growing investment returns - Autocar Professional
Bullish Pattern Emerging on G (532139)Consistent wealth multiplication - jammulinksnews.com
Top Stocks for Hedge Fund Investments Data Backed Investment TechniquesRemarkable growth - jammulinksnews.com
What drives China Pharma Holdings Inc. stock priceExponential return rates - Autocar Professional
What analysts say about China Pharma Holdings Inc. stockFree Popular Stock Recommendations - jammulinksnews.com
Big Pharma is increasingly reliant on Chinese biotech advances - Financial Times
Top Reasons to Buy CHIRP(chirp token)Balanced Risk Reward Portfolio - Newser
What analysts say about Corbus Pharmaceuticals Holdings Inc. stockOutstanding yields - jammulinksnews.com
Why IDAI stock attracts strong analyst attentionShort Squeeze Radar - Newser
JBM Auto Limited (JBMA)’s Trend in 2025Free Advanced Stock Screener Access - Autocar Professional
What drives SEACOR Marine Holdings Inc. stock pricePhenomenal investment performance - PrintWeekIndia
Top Real Estate Stocks Professional Trading PicksUnrivaled growth potential - Autocar Professional
Is BioCardia Inc. a good long term investmentSuperior trading gains - Autocar Professional
DB (International) Stock Brokers Limited (DBSTOCKBRO) Sees Unusual Trading VolumeSuperior risk-adjusted returns - Autocar Professional
Best AI Stocks in India Investment Group Stock AlertsFree Stock Movement Tracking - Autocar Professional
What drives Nomura Holdings Inc. Depositary Receipt stock priceUnrivaled growth potential - Autocar Professional
Can Paisalo Digital Limited (532900) Maintain Its ValuationPhenomenal returns - Autocar Professional
Top FMCG Stocks in India Trusted Stock SignalsSuperior investment outcomes - Autocar Professional
What analysts say about BSLKW stockFree Stock Selection - jammulinksnews.com
What drives Lightwave Logic Inc. stock priceDynamic capital growth - jammulinksnews.com
Insulation Limited (GODHA) Stock RalliesConsistently superior profits - jammulinksnews.com
What analysts say about DTSQR stockExponential wealth increase - jammulinksnews.com
Hertz Global Holdings Inc. Equity Warrant Stock Analysis and ForecastSkyrocketing investment returns - jammulinksnews.com
Is China Pharma Holdings Inc. a good long term investmentHigh-octane gains - jammulinksnews.com
Technical Analysis: Rudra Ecovation Limited (514010)Massive stock growth - jammulinksnews.com
China Pharma Holdings Inc. Stock Analysis and ForecastHigh-octane gains - jammulinksnews.com
Sunita Tools Limited (544001) Sees Unusual Trading VolumeRapid market gains - jammulinksnews.com
AI for Ad Targeting and PersonalizationReturn Maximized Portfolio Strategy - Newser
What drives IMAX stock priceConsistent wealth multiplication - jammulinksnews.com
Is ATH.PRC a good long term investmentSuperior profit margins - Jammu Links News
Best Technology Stocks Smart Money Trading SignalsExponential wealth increase - jammulinksnews.com
Is Bhageria Industries Limited (530803) a Good Long Term BetConsistently high yield - jammulinksnews.com
Pharma 50: The top pharma companies in the world for 2025 - drugdiscoverytrends.com
What drives CBRE Group Inc. stock priceHigh-impact stock picks - Jammu Links News
Best Stocks for Sector Rotation in India AI Driven Stock AnalysisFree Stock Movement Tracking - jammulinksnews.com
Where Could Mangalam Organics Limited (MANORG) Be HeadedExplosive portfolio gains - Jammu Links News
Will REVBW stock split in the near futureMassive Gain Ideas - Newser
China Pharma Holdings Inc. Stock (CPHI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):